The coexpression of BCL6 and IL21 in some of these PD-1+ cells indicates that Tfh differentiation occurs in the tumor microenvironment, presumably through the repeated and chronic exposure to quasi-self antigens (i.e., tumor antigens). Here, BCL6 is linked to neoplasm.